[ad_1] Last Friday, a team led by scientists from the Max Planck Institute for Medical Research in Germany, published in Science Advances a study on the possibility of new ophthalmic clinical intervention …
Read More »ISP removes medications for hypertensive patients with a carcinogenic impurity
[ad_1] The Institute of Public Health of Chile (ISP) reported that the occurrence of an impurity, probably carcinogenic, has been detected in some drugs containing the active ingredient Valsartan, which is why …
Read More »ISP removes hypertension medications that contain valsartan
[ad_1] The Public Health Institute (ISP) announced the withdrawal of antihypertensive drugs containing the active ingredient Valsartan as a preventive measure, after having detected an "impurity, probably carcinogenic". a statement, the agency …
Read More »